Renee Ryan's most recent trade in NeuroPace Inc was a trade of 8,745 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeuroPace Inc | Renee Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 8,745 | 8,745 | - | - | Stock Option (right to buy) | |
| NeuroPace Inc | Renee Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 17,774 | 17,774 | - | - | Stock Option (Rt to Buy) | |
| NeuroPace Inc | Renee Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 27,380 | 27,380 | - | - | Stock Option (Rt to Buy) | |
| NeuroPace Inc | Renee Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 18,253 | 18,253 | - | - | Stock Option (Right to Buy) | |
| NeuroPace Inc | Renee Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2021 | 21,698 | 21,698 | - | - | Stock Option (Right to Buy) |